Advanced Oncotherapy announces the appointment of an Executive Chairman at subsidiary ADAM
Advanced Oncotherapy announces that Professor Steve Myers OBE, Head of Medical Applications at CERN, has been appointed as Executive Chairman of Advanced Oncotherapy’s fully owned subsidiary ADAM S.A. ADAM was founded in 2007 as a spin-off from CERN, the European Organisation for Nuclear Research, and was acquired by Advanced Oncotherapy in 2013. The ADAM team […]
Advanced Oncotherapy announces the disposal of Oncotherapy Resources Ltd
Advanced Oncotherapy announces that it has disposed of its subsidiary, Oncotherapy Resources Ltd (“ORL”), for a total cash consideration of £100,000. An initial cash payment of £75,000 has been received with the remainder to be paid on the first anniversary of the disposal. ORL focuses on supplying a fully mobile managed service delivering electronic brachytherapy […]
Advanced Oncotherapy announces the successful high power testing of two Coupled Cavity Linac (CCL) modules
Advanced Oncotherapy announces that the high power testing of two Coupled Cavity Linac (CCL) modules at the Company’s facility in Geneva has been successfully completed. In August the Company announced that the two CCL modules were ready to be tested at high power and marked the first time two CCL modules were tested together. The modules have […]
Malcolm Stacey of ShareProphets – My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacta & Advanced Oncotherapy
Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of […]
Advanced Oncotherapy (AVO) – Discussed by Mark Brewer – Hardman & Co Analyst
Mark Brewer – Hardman & Co Life Sciences Analyst discusses with DirectorsTalk Advanced Oncotherapy Plc, it’s unique technology, the market size, growth drivers, key risks and an outlook for the company.
Advanced Oncotherapy CEO discusses the second commercial sale of proton therapy system in China
Advanced Oncotherapy CEO Sanjeev Pandya discusses the second commercial sale of proton therapy system in China – BRR Media
Advanced Oncotherapy announces 2nd commercial sale of proton therapy system in China, plus further agreements for four new proton therapy centres.
Advanced Oncotherapy announces the second commercial sale of proton therapy system in China, plus further Framework Agreements for four new proton therapy centres. Advanced Oncotherapy announces that, further to the announcement of 20 August 2015, it has now received a purchase order for its LIGHT machine from the China-Japan Union Hospital of Jilin University, through […]
Advanced Oncotherapy (AVO) – “With every announcement the credibility grows”
Advanced Oncotherapy “with every announcement the credibility grows” Advanced Oncotherapy (AVO) announced yesterday that it has signed a joint venture agreement with CircleHealth to operate the Company’s proton beam cancer therapy centre in Harley Street. CircleHealth, owned by AIM-listed Circle Holdings plc (CIRC) which is an employee co-owned company, runs hospitals and healthcare across the […]
Advanced Oncotherapy announces Operator agreement with CircleHealth for Harley St site
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has signed a joint venture agreement with CircleHealth to operate the Company’s proton beam cancer therapy centre in Harley Street. Circle, owned by AIM-listed Circle Holdings plc (CIRC) which is an employee co-owned company, runs hospitals and healthcare across […]
Advanced Oncotherapy (AVO) wins Best Technology Award at the AIM Awards 2015
Advanced Oncotherapy (AVO) wins Best Technology Award at the AIM Awards 2015. Sponsored by | Sanlam Securities UK Picture shows, left to right: David Snell, Partner and AIM Leader, PwC; David Worlidge, Director, Corporate Finance, Sanlam Securities UK; Robert Rose, Operations and Manufacturing Director, Advanced Oncotherapy plc and Graham Pughe, Chief Accounting Officer and Vice […]